Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC “correct to highlight” provision of free services, sector says

Community pharmacy has largely come out in favour of the Pharmaceutical Services Negotiating Committee’s (PSNC) calls for contractors to stop providing unfunded free services.

Last week (August 21), the Pharmaceutical Services Negotiating Committee (PSNC) called for pharmacy owners to “reconsider” providing services that are not part of the community pharmacy contractual framework for free.

The call to action came as PSNC branded the financial situation that pharmacies are in as “very treacherous”, and said more funding is needed for the sector.

A spokesperson for the Company Chemists’ Association (CCA)  told C+D on Friday (August 21) that the CCA “agrees that free services may well not be sustainable in the current financial climate and that each business will be faced with some hard decisions”.

Patient care has been a priority for pharmacies throughout the pandemic and will remain so, they added.

The representative body “fully supports PSNC’s work to negotiate funding for the full costs for contractors of operating during COVID-19 and funding for the future”, the spokesperson added.

AIMp: Funding model must reflect sector

Association of Independent Multiple Pharmacies chief executive Leyla Hannbeck told C+D today (August 24) that “as pharmacy moves towards a more service-based and clinical network, the funding model will need to move to reflect these changes”.

“The sector’s credentials of access, convenience and resilience have never been so visible or effective as they are today,” she said. AIMp believes the “decision to do more for the same” should now be “superseded by real investment in the sector,” Ms Hannbeck  continued.

However, a change to the funding  setup to reflect the move towards a service-based pharmacy model is “unlikely to be achieved with safety and stability if, at the same time, oversimplified assumptions are being made about the cost of providing the core service,” Ms Hannbeck said.

“In our opinion, it is correct to highlight that some patient-supporting features are not sustainable indefinitely and to instigate public debate,” she added.

RPS: Government must back pharmacy with funding

Professor Claire Anderson, chair of the Royal Pharmaceutical Society English board, told C+D today that the government “now needs to back pharmacy with fair funding, so it can continue supporting patients in the months ahead,” especially in light of the possibility of a “second wave” of COVID-19.

Community pharmacy teams “deserve to be recognised for the role they play and the services they provide”, she added.

“Free services are a lifeline to many patients”

Commenting on PSNC’s advice to contractors, Nat Mitchell, pharmacist and director of JWW Allison in Cockermouth, Cumbria said that while he agrees with the advice “in principle”, he is “not quite sure how you would put this into practice without compromising patient care and your reputation”.

“I know that many will say it’s our own fault and maybe they’re correct, but it doesn’t change the fact that free services such as deliveries are a lifeline to many patients. It just shouldn’t be us who are funding it,” he told C+D today.

Babir Malik, a community pharmacist based in Yorkshire, said the PSNC's statement is " long overdue".

"The profession, while caring, has been too nice for [its] own good," he added.

Do you provide free services to patients?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel